Global /Taiwan /Healthcare /Drug Manufacturers - General /4111
chevron_leftBack
Chi Sheng Pharma & Biotech Co., Ltd. logo

Chi Sheng Pharma & Biotech Co., Ltd.

4111
TPEX: 4111 Delayed
29.45TWD 0.3%
0.9321 USD
As of 6 June 2026, Chi Sheng Pharma & Biotech Co., Ltd. has a market cap of $56.02M USD, ranking #29790 globally and #1773 in Taiwan. It ranks #2693 in the Healthcare sector, and #953 in the Drug Manufacturers - General industry.
Global Rank
29790
Country Rank
1773
Sector Rank
2693
Industry Rank
953
Key Stats
Market Cap
$56.02MUSD
1.76B TWD
Enterprise Value
$42.47MUSD
1.34B TWD
Revenue (TTM)
$43.76MUSD
1.38B TWD
EBITDA (TTM)
$8.66MUSD
273.56M TWD
Net Income (TTM)
$5.22MUSD
164.28M TWD
EBITDA Margin
20%
Profit Margin
12%
PE Ratio
10.8
PS Ratio
1.3
PB Ratio
1.3
EV/EBITDA
4.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dongmao Su open_in_new
Founded
1962
Website
cscp.com.tw open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.3% 0.5% 0.5% -2.3% -2.5% 0.1%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
4111
濟生醫藥生技股份有限公司
ISIN: TW0004111000
Shares Out.:
59.832M1 Shares Float: 50.935M2
TV:
SA:
YF:
GF:
BA:
MS:
29.45 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Chi Sheng Pharma & Biotech Co., Ltd.

Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerve agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and anti-asthmatics; gastro-intestinal preparations; local anesthetic preparations; hemodialysis concentrate and external solutions; peritoneal dialysis solutions; and others. The company also offers medical devices, fat emulsion products, anesthetic products, hemostatic solutions, food and health food products, functional drinks, skin care products and cosmetics, and veterinary medicinal products. In addition, it provides externally applied medicines, including contact lens, and salt and iodine solutions. Chi Sheng Pharma & Biotech Co., Ltd was founded in 1962 and is headquartered in Hukou, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)
Name
Market Cap diff.
PE
$7.8B
245.34B TWD
14K%
48.6
$1.84B
57.95B TWD
3K%
12.2
$925.55M
29.11B TWD
2K%
3.4
$809.3M
25.46B TWD
1K%
-
$789.12M
24.82B TWD
1K%
-
$584.14M
18.38B TWD
943%
11.8
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
1M%
38.1
JNJ
$547.28B
977K%
26.4
ABBV
$360.63B
644K%
97.4
$324.68B
256.25B CHF
580K%
19.9
AZN
$289.43B
215.59B GBP
517K%
27.6
NOVN
$277.35B
218.9B CHF
495K%
20.5
chevron_leftBack